Veterinary Research Forum
Vet Res Forum

Thiazolidines: Potential anti-viral agents against avian influenza and ‎infectious bronchitis viruses

Document Type : Short Communication

Authors

Sara Musaddiq 1
Mirza Imran Shahzad 2
Farzana Firdous 1
Atia Iqbal 3
Mehwish Tanveer 1
Abida Ashraf 1
Samina Aslam 1
Samia Khakwani 1

1 Department of Chemistry, Faculty of Science, The Women University Multan, Multan, Pakistan‎

2 Department of BioChemistry, Faculty of Science, The Islamia University of Bahawalpur, Bahawalpur, Pakistan‎

3 ‎Department of Microbiology and Molecular Genetics, Faculty of Life Sciences, Kutchery Campus, The Women University Multan, Multan, ‎Pakistan

https://doi.org/10.30466/vrf.2018.91264.2211
Abstract
Viral outbreaks are a common cause of morbidity and mortality in livestock and human populations. Lack of good vaccines and poor control measures along with natural viral genetic drifting and shifting are the common causes of new viral strains and outbreaks. The current study reports the synthesis of some 2-aryl substituted thiazolidine-4-carboxylic acids 1a-h and their 3-acetyl 2a and 3-benzoyl derivatives 3a. Two important poultry viruses: Avian influenza virus (AIV; A/Chicken/Italy/1994/H9N2) and infectious bronchitis virus (IBV) were selected, grown in ‎9-11 days old chicken embryonated eggs‎, and subjected to in ovo anti-viral assays. Most of the synthesized compounds were found active against AIV subtype H9N2 and IBV. In the case of AIV, the best results were attained for compound 1d which showed an IC50 value of 3.47 µM, while IBV 1c showed IC50 valueof4.10 µM. The lower IC50 values of these compounds correlate with the high potency of these compounds, especially in comparison with control groups. The standard drugs amantadine and ribavarin were used as positive controls in the case of AIV and IBV, respectively. Better results were obtained with 2-aryl substituted thiazolidine-4-carboxylic acids 1a-h compared to their N-acylated derivatives 2a and 3a against both viruses. In conclusion, this preliminary data support the idea that thiazolidine carboxylic acids could be used as anti-viral drugs against AIV and IBV infections.

Keywords

‎1, 3-thiazolidine-4- carboxylic acids
‎ Anti-viral activity
‎ Anti-viral inhibitors
‎ N-acylation ‎
  1. Wang H, Zhang Z, Chen Z, et al. High genetic diversity and frequent genetic reassortment of avian influenza A (H9N2) viruses along the East Asian–Australian migratory flyway. Infect Genet Evol 2016; 39: 325-329.
  2. Lin J, Xia J, Chen YT, et al. H9N2 avian influenza virus enhances the immune responses of BMDCs by down-regulating miR29c. Vaccine 2017; 35(5):729-737.
  3. Li KS, Xu KM, Peiris JSM, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 2003; 77(12): 6988-6994.
  4. Yang X, Zhou Y, Li J, et al. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge. Arch Virol2016; 161(5): 1209-1216.
  5. Boltz DA, Aldridge Jr JR, Webster RG, et al. Drugs in development for influenza. Drugs 2017; 70(11): 1349-1362. 
  6. Song ZC, Ma GY, Lv PC, et al. Synthesis, structure and structure–activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents. Europ J Med Chem 2009; 44(10):3903-3908.
  7. Mori M, Takagi M, Noritake C, et al. 2,4-Dioxo-1,3-thiazolidine derivatives as a lead for new fungicides. J Pestic Sci 2008; 33(4): 357-363.
  8. Oya M, Baba T, Kato E, et al. Synthesis and antihypertensive activity of N-(mercaptoacyl)-thiazolidinecarboxylic acids. Chem Pharm Bull (Tokyo) 1982; 30: 440-461.
  9. Abid DS, Shihab NL, Kamounah FS, Synthesis, characterization and structure activity relationship analysis of N-acetyl-2-substituted phenyl thiazolidine-4-carboxylic acids derivatives as neuraminidase inhibitors. J Chem Pharm Res 2014; 6 (11): 845-854.
  10. Frimayanti N, Lee VS, Zain SM, et al. 2D, 3D-QSAR, and pharmacophore studies on thiazolidine-4-carboxylic acid derivatives as neuraminidase inhibitors in H3N2 influenza virus. Med Chem Res 2014; 23(3),1447-1453.
  11. Gududuru V, Hurh E, Dalton JT, et al. Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer. J Med Chem 2005; 48(7):2584-2588.
  12. Melo TMVDP, Gomes CSB, Gonsalves AMAR, et al. Cycloaddition reactions of 3- aryl-5-phenyl-5H,7H thiazolo [3,4-c] oxazol-4-ium-1-olates. Tetrahedron 2002; 58: 5093-5102.
  13. Sulaiman LK, Oladele OA, Shittu IA, et al. In-ovo evaluation of the antiviral activity of methanolic root-bark extract of the African Baobab (Adansonia digitata Lin). Afr J Biotechnol 2011; 10(20):4256-4258.
  14. Wang J-X, Zhou J-Y, Yang Q-W, et al. An improved embryonated chicken egg model for the evaluation of antiviral drugs against influenza A virus. J Virol Methods 2008;153(2):218-222.
  15. Sekhar KC, Janardhan A, Kumar YN, et al.Amino acid esters substituted phosphorylated emtricitabine and didanosine derivatives as antiviral and anticancer agent. Appl Biochem Biotechnol 2014; 173:1303-1318.
  16. Song JM, Park KD, Lee KH, et al. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. Antiviral Res 2007; 76(2):178-185.
  17. Harrison SM, Tarpey I, Rothwell L, et al. Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture. Avian Pathol 2007; 36(2):109-114.
  18. Hirst GK. The quantitative determination of influenza virus and antibodies by means of red cell agglutination. J Exp Med 1942; 75(1):49-64.
  19. OIE, Manual of diagnostic tests and vaccines for terrestrial animal (mammals, birds and bees) 7th ed. Paris, France: OIE 2012: 1404.
  20. Liu Y, Jing F, Xu Y, et al. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors. Bioorg Med Chem 2011; 19(7): 2342-2348.
  21. Ha YM, Park YJ, Lee JY, et al. Design, synthesis and biological evaluation of 2-(substituted phenyl) thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors. Biochimie 2012; 94(2):533-540.
  22. Skvortsov AN, Uvarov VM, de Vekki DA, et al. Conformational analysis, spectral and catalytic properties of 1, 3-thiazolidines, ligands for acetophenone hydrosilylation with diphenylsilane. Russ J Gen Chem 2010; 80: 2007-2021.
  23. Bayram FEÖ, Sipahi H, Acar ET, et al. The cysteine releasing pattern of some antioxidant thiazolidine-4-carboxylic acids. Eur J Med Chem 2016; 114:337-344.
  24. Aslam A, Shahzad MI, Parveen S, et al. Evaluation of antiviral potential of different cholistani plants against infectious bursal disease and infectious bronchitis virus. Pak Vet J 2016; 36(3):302-306.
  25. Deng Y, He S, Geng Q, et al. Synthesis and biological activity evaluation of novel amino acid derivatives as potential elicitors against Tomato yellow leaf curl virus. Amino Acids 2015; 47:2495-2503.
  26. Xiao H, Li P, Hu D, et al. Synthesis and anti-TMV activity of novel β-amino acid ester derivatives containing quinazoline and benzothiazole moieties. Bioorg Med Chem Lett 2014; 24(15), 3452-3454.
Veterinary Research Forum
Volume 11, Issue 4
Autumn 2020
Pages 415-421

  • Receive Date 04 August 2018
  • Revise Date 17 October 2018
  • Accept Date 03 November 2018

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us